These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19561324)

  • 1. Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation.
    Kandilci A; Grosveld GC
    Blood; 2009 Aug; 114(8):1596-606. PubMed ID: 19561324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
    Morosetti R; Park DJ; Chumakov AM; Grillier I; Shiohara M; Gombart AF; Nakamaki T; Weinberg K; Koeffler HP
    Blood; 1997 Oct; 90(7):2591-600. PubMed ID: 9326225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of MN1 sequences necessary for myeloid transformation.
    Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
    PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.
    Wang XS; Gong JN; Yu J; Wang F; Zhang XH; Yin XL; Tan ZQ; Luo ZM; Yang GH; Shen C; Zhang JW
    Blood; 2012 May; 119(21):4992-5004. PubMed ID: 22493297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
    Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
    J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia.
    Sharma A; Jyotsana N; Gabdoulline R; Heckl D; Kuchenbauer F; Slany RK; Ganser A; Heuser M
    Haematologica; 2020 May; 105(5):1294-1305. PubMed ID: 31413090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HoxA9 binds and represses the Cebpa +8 kb enhancer.
    Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
    PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
    Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
    Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
    Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
    Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
    Guo H; Cooper S; Friedman AD
    PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.
    Avellino R; Havermans M; Erpelinck C; Sanders MA; Hoogenboezem R; van de Werken HJ; Rombouts E; van Lom K; van Strien PM; Gebhard C; Rehli M; Pimanda J; Beck D; Erkeland S; Kuiken T; de Looper H; Gröschel S; Touw I; Bindels E; Delwel R
    Blood; 2016 Jun; 127(24):2991-3003. PubMed ID: 26966090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro.
    Jiang J; Gao Q; Gong Y; Huang L; Lin H; Zhou X; Liang X; Guo W
    Cancer Med; 2018 Sep; 7(9):4627-4638. PubMed ID: 30073773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors.
    Pundhir S; Bratt Lauridsen FK; Schuster MB; Jakobsen JS; Ge Y; Schoof EM; Rapin N; Waage J; Hasemann MS; Porse BT
    Cell Rep; 2018 May; 23(9):2744-2757. PubMed ID: 29847803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
    Zjablovskaja P; Kardosova M; Danek P; Angelisova P; Benoukraf T; Wurm AA; Kalina T; Sian S; Balastik M; Delwel R; Brdicka T; Tenen DG; Behre G; Fiore F; Malissen B; Horejsi V; Alberich-Jorda M
    Cell Death Differ; 2017 Apr; 24(4):705-716. PubMed ID: 28186500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
    Koschmieder S; D'Alò F; Radomska H; Schöneich C; Chang JS; Konopleva M; Kobayashi S; Levantini E; Suh N; Di Ruscio A; Voso MT; Watt JC; Santhanam R; Sargin B; Kantarjian H; Andreeff M; Sporn MB; Perrotti D; Berdel WE; Müller-Tidow C; Serve H; Tenen DG
    Blood; 2007 Nov; 110(10):3695-705. PubMed ID: 17671235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
    Kawagoe H; Grosveld GC
    Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.
    Wilson M; Tsakraklides V; Tran M; Xiao YY; Zhang Y; Perkins AS
    J Biol Chem; 2016 Jun; 291(26):13591-607. PubMed ID: 27129260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.
    Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE
    J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.